Literature DB >> 27636738

High-Resolution Analysis of Antibodies to Post-Translational Modifications Using Peptide Nanosensor Microarrays.

Jung-Rok Lee, D James Haddon, Nidhi Gupta1, Jordan V Price2, Grace M Credo1, Vivian K Diep, Kyunglok Kim, Drew A Hall3, Emily C Baechler4, Michelle Petri5, Madoo Varma1, Paul J Utz6, Shan X Wang.   

Abstract

Autoantibodies are a hallmark of autoimmune diseases such as lupus and have the potential to be used as biomarkers for diverse diseases, including immunodeficiency, infectious disease, and cancer. More precise detection of antibodies to specific targets is needed to improve diagnosis of such diseases. Here, we report the development of reusable peptide microarrays, based on giant magnetoresistive (GMR) nanosensors optimized for sensitively detecting magnetic nanoparticle labels, for the detection of antibodies with a resolution of a single post-translationally modified amino acid. We have also developed a chemical regeneration scheme to perform multiplex assays with a high level of reproducibility, resulting in greatly reduced experimental costs. In addition, we show that peptides synthesized directly on the nanosensors are approximately two times more sensitive than directly spotted peptides. Reusable peptide nanosensor microarrays enable precise detection of autoantibodies with high resolution and sensitivity and show promise for investigating antibody-mediated immune responses to autoantigens, vaccines, and pathogen-derived antigens as well as other fundamental peptide-protein interactions.

Entities:  

Keywords:  autoantibody; giant magnetoresistance; lupus; nanosensors; peptide microarray; regeneration

Mesh:

Substances:

Year:  2016        PMID: 27636738      PMCID: PMC5367622          DOI: 10.1021/acsnano.6b03786

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  57 in total

1.  Peptide and small molecule microarray for high throughput cell adhesion and functional assays.

Authors:  J R Falsey; M Renil; S Park; S Li; K S Lam
Journal:  Bioconjug Chem       Date:  2001 May-Jun       Impact factor: 4.774

2.  Molecular signatures of antinuclear antibodies-contributions of heavy chain CDR residues.

Authors:  Leian Chen; Sooghee Chang; Chandra Mohan
Journal:  Mol Immunol       Date:  2002-10       Impact factor: 4.407

Review 3.  Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens.

Authors:  P J Utz; P Anderson
Journal:  Arthritis Rheum       Date:  1998-07

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.

Authors:  H Golding; G M Shearer; K Hillman; P Lucas; J Manischewitz; R A Zajac; M Clerici; R E Gress; R N Boswell; B Golding
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  Autoantibody signatures in prostate cancer.

Authors:  Xiaoju Wang; Jianjun Yu; Arun Sreekumar; Sooryanarayana Varambally; Ronglai Shen; Donald Giacherio; Rohit Mehra; James E Montie; Kenneth J Pienta; Martin G Sanda; Philip W Kantoff; Mark A Rubin; John T Wei; Debashis Ghosh; Arul M Chinnaiyan
Journal:  N Engl J Med       Date:  2005-09-22       Impact factor: 91.245

7.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

8.  Self-assembling protein microarrays.

Authors:  Niroshan Ramachandran; Eugenie Hainsworth; Bhupinder Bhullar; Samuel Eisenstein; Benjamin Rosen; Albert Y Lau; Johannes C Walter; Joshua LaBaer
Journal:  Science       Date:  2004-07-02       Impact factor: 47.728

9.  Matrix-insensitive protein assays push the limits of biosensors in medicine.

Authors:  Richard S Gaster; Drew A Hall; Carsten H Nielsen; Sebastian J Osterfeld; Heng Yu; Kathleen E Mach; Robert J Wilson; Boris Murmann; Joseph C Liao; Sanjiv S Gambhir; Shan X Wang
Journal:  Nat Med       Date:  2009-10-11       Impact factor: 53.440

10.  Portable, one-step, and rapid GMR biosensor platform with smartphone interface.

Authors:  Joohong Choi; Adi Wijaya Gani; Daniel J B Bechstein; Jung-Rok Lee; Paul J Utz; Shan X Wang
Journal:  Biosens Bioelectron       Date:  2016-04-19       Impact factor: 10.618

View more
  5 in total

1.  Magnetic supercluster particles for highly sensitive magnetic biosensing of proteins.

Authors:  Songeun Kim; Junyoung Kim; Jisoo Im; Minah Kim; Taehyeong Kim; Shan X Wang; Dokyoon Kim; Jung-Rok Lee
Journal:  Mikrochim Acta       Date:  2022-06-14       Impact factor: 6.408

2.  Longitudinal Monitoring of Antibody Responses against Tumor Cells Using Magneto-nanosensors with a Nanoliter of Blood.

Authors:  Jung-Rok Lee; Carmel T Chan; Daniel Ruderman; Hui-Yen Chuang; Richard S Gaster; Michelle Atallah; Parag Mallick; Scott W Lowe; Sanjiv S Gambhir; Shan X Wang
Journal:  Nano Lett       Date:  2017-10-20       Impact factor: 11.189

3.  Longitudinal Multiplexed Measurement of Quantitative Proteomic Signatures in Mouse Lymphoma Models Using Magneto-Nanosensors.

Authors:  Jung-Rok Lee; Iris Appelmann; Cornelius Miething; Tyler O Shultz; Daniel Ruderman; Dokyoon Kim; Parag Mallick; Scott W Lowe; Shan X Wang
Journal:  Theranostics       Date:  2018-02-03       Impact factor: 11.556

4.  Design and Fabrication of Full Wheatstone-Bridge-Based Angular GMR Sensors.

Authors:  Shaohua Yan; Zhiqiang Cao; Zongxia Guo; Zhenyi Zheng; Anni Cao; Yue Qi; Qunwen Leng; Weisheng Zhao
Journal:  Sensors (Basel)       Date:  2018-06-05       Impact factor: 3.576

5.  Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies.

Authors:  Lingyun Xu; Jung-Rok Lee; Shiying Hao; Xuefeng Bruce Ling; James D Brooks; Shan X Wang; Sanjiv Sam Gambhir
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.